Rein Therapeutics
RNTX
HK$13.20
Share price
0.00%
Change (1 day)
-72.80%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -HK$15.48
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$15.38. In 2023 the company made an earnings per share (EPS) of -HK$26.56 an increase over its 2022 EPS that were of -HK$46.76.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -HK$15.48 | -41.74% |
| 2023 | -HK$26.56 | -43.19% |
| 2022 | -HK$46.76 | 2.21% |
| 2021 | -HK$45.75 | -51.72% |
| 2020 | -HK$94.76 | -49.17% |
| 2019 | -HK$186.41 | -43.93% |
| 2018 | -HK$332.44 | -29.61% |
| 2017 | -HK$472.25 | 82.33% |
| 2016 | -HK$259.01 | 40.54% |
| 2015 | -HK$184.30 |